YBX1 and neoplasm: To further identify the antiangiogenic role of YB1 CTD in SK‐BR‐3 tumour‐bearing mice, immunohistochemistry was performed to examine VEGF and CD31 expressions, as well as angiogenesis in transplanted tumour tissues.